6-25768985-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_005495.3(SLC17A4):c.92G>A(p.Gly31Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005495.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC17A4 | NM_005495.3 | c.92G>A | p.Gly31Asp | missense_variant, splice_region_variant | 3/12 | ENST00000377905.9 | NP_005486.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC17A4 | ENST00000377905.9 | c.92G>A | p.Gly31Asp | missense_variant, splice_region_variant | 3/12 | 1 | NM_005495.3 | ENSP00000367137 | P1 | |
SLC17A4 | ENST00000397076.2 | c.-71G>A | splice_region_variant, 5_prime_UTR_variant | 3/7 | 2 | ENSP00000380266 | ||||
SLC17A4 | ENST00000439485.6 | c.-71G>A | splice_region_variant, 5_prime_UTR_variant | 4/13 | 5 | ENSP00000391345 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.92G>A (p.G31D) alteration is located in exon 3 (coding exon 2) of the SLC17A4 gene. This alteration results from a G to A substitution at nucleotide position 92, causing the glycine (G) at amino acid position 31 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at